Excitotoxicity: Still Hammering the Ischemic Brain in 2020.

Front Neurosci · 2020 · PMC7649323 · PMID 33192266

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

(2016) , and a Phase IIb clinical trial (URICO-ICTUS) examining the effect of a 1 g dose administered together with tPA showed a trend toward better outcomes at 90 days ( Chamorro et al., 2014 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.